Customer Oceanfront Recovery Expands SOBRsafe Technology Use

Rhea-AI Summary

SOBR Safe, Inc. (NASDAQ:SOBR) announced the success of its SOBRsure Wearable Band in outpatient monitoring, with Oceanfront Recovery expanding its use of SOBRcheck to its two inpatient treatment facilities. The company's alcohol detection solutions have been well-received, with positive outcomes and unexpected benefits reported by clients.

Insights

Market Research Analyst

SOBR Safe, Inc.'s announcement that Oceanfront Recovery is expanding its use of the SOBRcheck system to its inpatient facilities signifies a potential increase in the product's market penetration within the addiction treatment industry. This expansion reflects a vote of confidence in the technology's efficacy and could lead to similar adoption by other treatment centers, thereby increasing revenue streams for SOBR Safe, Inc. The mention of empirical data supporting over 120 consecutive days of sobriety for a client using the SOBRsure wearable band suggests that the product is not only technologically sound but also effective in real-world applications, which can be a powerful marketing tool.

The adoption of SOBRsure by judges for outpatient compliance indicates institutional validation, possibly paving the way for more widespread judicial endorsement. This could result in a more stable demand for the product, as it becomes integrated into legal frameworks for monitoring alcohol consumption. However, it is important to monitor the long-term reliability and user compliance with the wearable technology, as these factors will be critical in determining the product's success and the company's financial health.

Medical Technology Analyst

The transition from traditional breathalyzers to transdermal alcohol detection solutions like SOBRcheck and SOBRsure reflects a broader trend in medical technology towards non-invasive, continuous monitoring systems. The ability of SOBRsafe's products to offer rapid and accurate verification of alcohol absence may provide a competitive advantage over existing technologies. The reported intrinsic accountability and reduced relapse rates associated with wearing the SOBRsure band suggest that the device's design is conducive to patient adherence and could lead to improved treatment outcomes.

It is also noteworthy that the product is being integrated into judicial systems for outpatient compliance, which may signify a new niche market for medical monitoring technologies. However, the scalability of production and the ability to maintain product quality as demand increases are factors that need consideration. Additionally, as the healthcare industry is highly regulated, ongoing compliance with regulatory standards is essential for the sustained success of medical technology products like those offered by SOBR Safe, Inc.

Healthcare Industry Analyst

The expansion of SOBRcheck's use in Oceanfront Recovery's inpatient facilities indicates potential growth in the healthcare sector's adoption of innovative alcohol monitoring solutions. This growth could be bolstered by positive patient outcomes and the device's perceived role in supporting sobriety. The healthcare industry's increasing focus on patient-centered care and outcomes may drive further interest in technologies that support patient autonomy and accountability.

However, the long-term impact on SOBR Safe, Inc.'s financials will depend on the product's continued performance, competitive landscape and the ability to secure further contracts with healthcare providers. As the industry is subject to shifts in policy and funding, particularly in the behavioral health space, the company must navigate these changes adeptly. The partnership with a single recovery center, while promising, is not necessarily indicative of broader market trends and further evidence of adoption across multiple centers would provide a stronger signal of the product's market viability.

Oceanfront Also Reports on the Success of SOBRsure Wearable Band in Outpatient Monitoring

DENVER, CO / ACCESSWIRE / January 5, 2024 / SOBR Safe, Inc. (NASDAQ:SOBR) ("SOBRsafe"), providers of next-generation transdermal alcohol detection solutions, today announced that current customer Oceanfront Recovery has expanded its use of SOBRcheck™ to its two inpatient treatment facilities. Based in Laguna Beach, California, Oceanfront previously installed SOBRcheck at its headquarters, and deployed SOBRsure™ for continuous client monitoring.

Expanded SOBRcheck Use

"We have had SOBRcheck installed at our headquarters since September, and it has been an invaluable tool for client compliance check-in," stated Oceanfront Recovery President and COO Keenen Diamond. "It empowers us to verify the absence of alcohol in a rapid, accurate way, replacing breathalyzers for our everyday use. Based on the success of this initial implementation, we are excited to roll the SOBRcheck technology out to our treatment centers and ensure safe and alcohol-free environments of care."

SOBRsure Helping to Change Lives

Followed Mr. Diamond, "We also have clients utilizing the SOBRsure wearable band for outpatient compliance purposes, as approved by multiple judges here in Orange County. SOBRsure's continuous, passive monitoring has been a welcome change from traditional remote breath products, and it has led to positive outcomes - we are pleased to report one client wearing SOBRsure has now achieved over 120 consecutive days of sobriety, as empirically demonstrated through the SOBRsure app.

"Our clients have also shared an unexpected benefit of wearing the sleek, fitness-style SOBRsure - seeing it physically on their wrist has created intrinsic accountability and reduced relapse rates. We did not expect the device to go well beyond monitoring and actually become a positive reinforcement tool, rather than a policing device."---

About SOBRsafe™

Alcohol misuse is the fourth leading cause of preventable death in America, and the seventh worldwide. Yet prevention and monitoring solutions have not kept pace with this epidemic. Legacy technologies are invasive and inefficient, unhygienic and unconnected. There has to be a better way.

Enter SOBRsafe™. Our advanced transdermal (touch-based) technology detects and instantaneously reports the presence of alcohol as emitted through a user's skin - no breath, blood or urine sample is required. With a powerful backend data platform, SOBRsafe provides next generation, passive detection technology for the behavioral health, transportation, oil and gas, judicial and consumer markets.

The SOBRsafe technology is commercially available for access control (SOBRcheck), wearable use (SOBRsure) and licensing/white labeling. At SOBRsafe, we are creating a culture of prevention and support. To learn more, visit www.sobrsafe.com.

Contact SOBRsafe:
investor.relations@sobrsafe.com

Safe Harbor Statement

Our prospects here at SOBRsafe are subject to uncertainties and risks. This press release contains forward-looking statements that involve substantial uncertainties and risks. These forward-looking statements are based upon our current expectations, estimates and projections about our business, and reflect our beliefs and assumptions based upon information available to us at the date of this press release. In some cases, you can identify these statements by words such as "if," "may," "might," "will, "should," "expects," "plans," "anticipates," "believes," "estimates," "predicts," "potential," "continue," and other similar terms. These forward-looking statements include, among other things, plans for proposed operations, descriptions of our strategies, our product and market development plans, and other objectives, expectations and intentions, the trends we anticipate in our business and the markets in which we operate, and the competitive nature and anticipated growth of those markets. We caution readers that forward-looking statements are predictions based on our current expectations about future events. These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and assumptions that are difficult to predict. Our actual results, performance or achievements could differ materially from those expressed or implied by the forward-looking statements as a result of a number of factors including, but not limited to, the risks and uncertainties discussed under risk factors in our registration statement on Form S-1, (File No. 333-267882) as well as our other filings with the SEC. We undertake no obligation to revise or update any forward-looking statement for any reason.

SOURCE: SOBR Safe, Inc.

View the original press release on accesswire.com

FAQ

What did SOBR Safe, Inc. announce?

SOBR Safe, Inc. announced the success of its SOBRsure Wearable Band in outpatient monitoring, with Oceanfront Recovery expanding its use of SOBRcheck to its two inpatient treatment facilities.

What is the ticker symbol for SOBR Safe, Inc.?

The ticker symbol for SOBR Safe, Inc. is NASDAQ:SOBR.

Where is Oceanfront Recovery based?

Oceanfront Recovery is based in Laguna Beach, California.

What was the unexpected benefit of wearing the SOBRsure band?

The unexpected benefit of wearing the SOBRsure band reported by clients was that seeing it physically on their wrist created intrinsic accountability and reduced relapse rates.

What positive outcome was reported by Oceanfront Recovery?

Oceanfront Recovery reported that one client wearing SOBRsure achieved over 120 consecutive days of sobriety, as demonstrated through the SOBRsure app.